KMTS

$19.10-0.46 (-2.35%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Kestra Medical Technologies, Ltd.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPROTranscriptsPROStatementsPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$19.10
Potential Upside
5%
Whystock Fair Value$20.06
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitiv...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.11B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-80.55%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
5.27

Recent News

MarketBeat
Mar 18, 2026

Kestra Medical Technologies Q3 Earnings Call Highlights

Kestra Medical Technologies (NASDAQ:KMTS) reported what management described as a strong third quarter of fiscal 2026, highlighted by higher prescriptions, accelerating revenue growth, and continued gross margin expansion as the company scales its wearable cardioverter defibrillator (WCD) business a

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 18, 2026

KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary

Moby summary of KESTRA MEDICAL TECHNOLOGIES, LTD.'s Q3 2026 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 18, 2026

Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ...

Kestra Medical Technologies Ltd (KMTS) reports a 63% revenue increase, despite ongoing net losses and strategic investments in market expansion.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 16, 2026

Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You Need To Know Ahead Of Earnings

This article first appeared on GuruFocus. Kestra Medical Technologies Ltd (NASDAQ:KMTS) is set to release its Q3 2026 earnings on Mar 17, 2026. The consensus estimate for Q3 2026 revenue is $22.86 million, and the earnings are expected to come in at -$0.60 per share.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 18, 2026

Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value

Key Insights Kestra Medical Technologies' significant private equity firms ownership suggests that the key decisions...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.